Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease
- 30 November 2005
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1063 (2) , 201-203
- https://doi.org/10.1016/j.brainres.2005.09.028
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Orexin loss in Huntington's diseaseHuman Molecular Genetics, 2004
- Huntington?s disease: pathomechanism and therapeutic perspectivesJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2004
- Sleep and quantitative EEG in neurodegenerative disordersJournal of Psychosomatic Research, 2004
- CSF hypocretin (Orexin) in neurological and psychiatric conditionsJournal of Sleep Research, 2003
- The Role of Cerebrospinal Fluid Hypocretin Measurement in the Diagnosis of Narcolepsy and Other HypersomniasArchives of Neurology, 2002
- CSF hypocretin‐1 (orexin‐A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomniaJournal of Sleep Research, 2002
- CSF hypocretin/orexin levels in narcolepsy and other neurological conditionsNeurology, 2001
- The hypocretins: Excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feedingJournal of Neuroscience Research, 2000
- Declaration of Helsinki (1964)BMJ, 1996
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993